These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 29355746)
1. Bone remodelling in vitro: Where are we headed?: -A review on the current understanding of physiological bone remodelling and inflammation and the strategies for testing biomaterials in vitro. Kohli N; Ho S; Brown SJ; Sawadkar P; Sharma V; Snow M; García-Gareta E Bone; 2018 May; 110():38-46. PubMed ID: 29355746 [TBL] [Abstract][Full Text] [Related]
2. [Development, physiology, and cell activity of bone]. de Baat P; Heijboer MP; de Baat C Ned Tijdschr Tandheelkd; 2005 Jul; 112(7):258-63. PubMed ID: 16047964 [TBL] [Abstract][Full Text] [Related]
3. Co-culture systems of osteoblasts and osteoclasts: Simulating in vitro bone remodeling in regenerative approaches. Borciani G; Montalbano G; Baldini N; Cerqueni G; Vitale-Brovarone C; Ciapetti G Acta Biomater; 2020 May; 108():22-45. PubMed ID: 32251782 [TBL] [Abstract][Full Text] [Related]
4. Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts. Baum R; Gravallese EM Clin Rev Allergy Immunol; 2016 Aug; 51(1):1-15. PubMed ID: 26411424 [TBL] [Abstract][Full Text] [Related]
6. The biology of normal bone remodelling. Katsimbri P Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28786518 [TBL] [Abstract][Full Text] [Related]
7. The osteoclast, bone remodelling and treatment of metabolic bone disease. Boyce BF; Rosenberg E; de Papp AE; Duong LT Eur J Clin Invest; 2012 Dec; 42(12):1332-41. PubMed ID: 22998735 [TBL] [Abstract][Full Text] [Related]
8. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention. Kupisiewicz K Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989 [TBL] [Abstract][Full Text] [Related]
9. Use of in vitro bone models to screen for altered bone metabolism, osteopathies, and fracture healing: challenges of complex models. Ehnert S; Rinderknecht H; Aspera-Werz RH; Häussling V; Nussler AK Arch Toxicol; 2020 Dec; 94(12):3937-3958. PubMed ID: 32910238 [TBL] [Abstract][Full Text] [Related]
10. The role of osteoclasts in bone tissue engineering. Detsch R; Boccaccini AR J Tissue Eng Regen Med; 2015 Oct; 9(10):1133-49. PubMed ID: 24478169 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of bone turnover. Väänänen HK Ann Med; 1993 Aug; 25(4):353-9. PubMed ID: 8217101 [TBL] [Abstract][Full Text] [Related]
14. An overview of the regulation of bone remodelling at the cellular level. Kular J; Tickner J; Chim SM; Xu J Clin Biochem; 2012 Aug; 45(12):863-73. PubMed ID: 22465238 [TBL] [Abstract][Full Text] [Related]
15. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis. Cai X; Xing J; Long CL; Peng Q; Humphrey MB J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106 [TBL] [Abstract][Full Text] [Related]
16. The molecular mechanism behind bone remodelling: a review. Proff P; Römer P Clin Oral Investig; 2009 Dec; 13(4):355-62. PubMed ID: 19319579 [TBL] [Abstract][Full Text] [Related]
17. Giant cells around bone biomaterials: Osteoclasts or multi-nucleated giant cells? Miron RJ; Zohdi H; Fujioka-Kobayashi M; Bosshardt DD Acta Biomater; 2016 Dec; 46():15-28. PubMed ID: 27667014 [TBL] [Abstract][Full Text] [Related]
18. Regulation of cortical and trabecular bone mass by communication between osteoblasts, osteocytes and osteoclasts. Sims NA; Vrahnas C Arch Biochem Biophys; 2014 Nov; 561():22-8. PubMed ID: 24875146 [TBL] [Abstract][Full Text] [Related]
19. Hafnium (IV) oxide obtained by atomic layer deposition (ALD) technology promotes early osteogenesis via activation of Runx2-OPN-mir21A axis while inhibits osteoclasts activity. Seweryn A; Alicka M; Fal A; Kornicka-Garbowska K; Lawniczak-Jablonska K; Ozga M; Kuzmiuk P; Godlewski M; Marycz K J Nanobiotechnology; 2020 Sep; 18(1):132. PubMed ID: 32933533 [TBL] [Abstract][Full Text] [Related]